MLYS Prakiraan wutah bathi resik saben saham kanggo taun ngarep mineralystx.com

mineralystx.com (MLYS) - logo korporat

Mineralys Therapeutics (MLYS) is developing innovative hypertension treatments, aiming to outperform existing analogs in efficacy. The strategy focusing on daily medication for chronic patients promises a stable cash flow. Currently, Mineralys Therapeutics is focusing on R&D to facilitate the future sale of patents to industry behemoths. The projected EPS growth for next year visualizes market expectations, where 47.20 reflects the latest metric value.

MLYS - Prakiraan wutah bathi resik saben saham ing taun ngarep Mineralys Therapeutics Inc ing rentang 28.04.2023 - 17.11.2026

Mineralys Therapeutics Inc - rincian analitis lan metrik utama (MLYS)

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental:Mineralys Therapeutics, MLYS
Produk merek Mineralys

The success of Mineralys Therapeutics (MLYS) in the hypertension therapy segment depends directly on confirming that its innovations are superior to low-cost generics. Forward earnings per share dynamics reflect the mathematical growth forecast for EPS over the coming year, allowing investors to identify discrepancies in market expectations and rebalance portfolios in a timely manner by eliminating overheated positions with unjustifiably high yield expectations.

Analisis pesaing Mineralys Therapeutics

REGN (Regeneron Pharmaceuticals, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|IRTC: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep LNTH (lantheus.com)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep HTFL (HeartFlow Corp)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kestra Medical Corp KMTS|ESPR: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|AMRN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep anteristech.com|TNYA: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep CVRx, Inc|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Milestone Pharmaceuticals Inc.|Prakiraan wutah bathi resik saben saham ing taun ngarep cardiolrx.com CRDL|Prakiraan wutah bathi resik saben saham kanggo taun ngarep HeartBeam (BEAT)|TENX: Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ADGM (adagiomedical.com)|BCDA - Prakiraan wutah bathi saben saham kanggo taun ngarep|Catheter Precision Corporation - Prakiraan wutah bathi kanggo taun ngarep|ABIO - Prakiraan wutah bathi kanggo taun ngarep|ACST: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep AVTE (Aerovate Therapeutics)|VERV (Verve Therapeutics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Windtree Therapeutics, Inc. WINT